Journal of Histochemistry and Cytochemistry Priciples for Free Access to Science
  Search:   
    >> Advanced Search

Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alford, M. F.
Right arrow Articles by Terry, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alford, M. F.
Right arrow Articles by Terry, R. D.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

A simple dot-immunobinding assay for quantification of synaptophysin- like immunoreactivity in human brain

MF Alford, E Masliah, LA Hansen and RD Terry

Department of Neurosciences, University of California, San Diego 92093- 0624.

Neocortical decreases in synaptic density correlate significantly with the cognitive impairment seen in Alzheimer disease. Recently available monoclonal antibodies (MAb) have made possible the highly specific and sensitive detection of synapse-associated proteins in immunocytochemical and immunochemical techniques. We describe a simple yet highly sensitive dot-immunobinding assay for relative quantification of the synapse marker protein synaptophysin in human brain homogenate fractions with the mouse MAb SY38. Fractions prepared from control and Alzheimer specimens were blotted to nitrocellulose membranes and reacted with SY38, rabbit secondary antibody, and iodinated protein A. A relative standard curve was constructed to normalize results from multiple assay runs. We correlated the results with the more complex immunocytochemical synaptic density measurement technique of immunolabeling coupled with laser confocal imaging, showing good correlation at r = 0.821. Results from Alzheimer cases showed a 40% decrease in synaptophysin immunoreactivity in midfrontal cortex compared with normal controls.

Volume 42, Issue 2, pp. 283-287, 02/01/1994
Copyright © 1994 by The Histochemical Society


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Neurosci.Home page
J. Zhao, A. N. Moore, J. B. Redell, and P. K. Dash
Enhancing Expression of Nrf2-Driven Genes Protects the Blood Brain Barrier after Brain Injury
J. Neurosci., September 19, 2007; 27(38): 10240 - 10248.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
P. Tiraboschi, M. N. Sabbagh, L. A. Hansen, D. P. Salmon, A. Merdes, A. Gamst, E. Masliah, M. Alford, L. J. Thal, and J. Corey-Bloom
Alzheimer disease without neocortical neurofibrillary tangles: "A second look"
Neurology, April 13, 2004; 62(7): 1141 - 1147.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
P. Tiraboschi, L. A. Hansen, M. Alford, E. Masliah, L. J. Thal, and J. Corey-Bloom
The decline in synapses and cholinergic activity is asynchronous in Alzheimer's disease
Neurology, November 14, 2000; 55(9): 1278 - 1283.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
E. B. Mukaetova-Ladinska, F. Garcia-Siera, J. Hurt, H. J. Gertz, J. H. Xuereb, R. Hills, C. Brayne, F. A. Huppert, E. S. Paykel, M. McGee, et al.
Staging of Cytoskeletal and {beta}-Amyloid Changes in Human Isocortex Reveals Biphasic Synaptic Protein Response during Progression of Alzheimer's Disease
Am. J. Pathol., August 1, 2000; 157(2): 623 - 636.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
L. Mucke, E. Masliah, G.-Q. Yu, M. Mallory, E. M. Rockenstein, G. Tatsuno, K. Hu, D. Kholodenko, K. Johnson-Wood, and L. McConlogue
High-Level Neuronal Expression of Abeta 1-42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation
J. Neurosci., June 1, 2000; 20(11): 4050 - 4058.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
J. Corey-Bloom, P. Tiraboschi, L. A. Hansen, M. Alford, B. Schoos, M. N. Sabbagh, E. Masliah, and L. J. Thal
E4 allele dosage does not predict cholinergic activity or synapse loss in Alzheimer's disease
Neurology, January 25, 2000; 54(2): 403 - 403.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
M. N. Sabbagh, J. Corey-Bloom, P. Tiraboschi, R. Thomas, E. Masliah, and L. J. Thal
Neurochemical Markers Do Not Correlate With Cognitive Decline in the Lewy Body Variant of Alzheimer Disease
Arch Neurol, December 1, 1999; 56(12): 1458 - 1461.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. Masliah, J. Raber, M. Alford, M. Mallory, M. P. Mattson, D. Yang, D. Wong, and L. Mucke
Amyloid Protein Precursor Stimulates Excitatory Amino Acid Transport. IMPLICATIONS FOR ROLES IN NEUROPROTECTION AND PATHOGENESIS
J. Biol. Chem., May 15, 1998; 273(20): 12548 - 12554.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
L A Hansen, S E Daniel, G K Wilcock, and S Love
Frontal cortical synaptophysin in Lewy body diseases: relation to Alzheimer's disease and dementia
J. Neurol. Neurosurg. Psychiatry, May 1, 1998; 64(5): 653 - 656.
[Abstract] [Full Text] [PDF]



Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact
The Journal of Histochemistry & Cytochemistry is owned, published, and licensed by The Histochemical Society © 1994